StockNews.com cut shares of Edap Tms (NASDAQ:EDAP – Free Report) from a hold rating to a sell rating in a research note released on Monday morning.
Separately, HC Wainwright reiterated a “buy” rating and set a $19.00 price objective on shares of Edap Tms in a research report on Thursday, August 29th.
View Our Latest Report on EDAP
Edap Tms Trading Up 2.5 %
Edap Tms (NASDAQ:EDAP – Get Free Report) last announced its quarterly earnings results on Wednesday, August 28th. The medical equipment provider reported ($0.18) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.04). The business had revenue of $16.97 million for the quarter, compared to analysts’ expectations of $17.16 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. As a group, equities research analysts expect that Edap Tms will post -0.6 EPS for the current fiscal year.
Institutional Investors Weigh In On Edap Tms
Institutional investors have recently modified their holdings of the stock. Virtu Financial LLC bought a new position in Edap Tms in the 1st quarter worth approximately $82,000. Redhawk Wealth Advisors Inc. bought a new stake in Edap Tms in the third quarter worth about $36,000. BNP Paribas Financial Markets boosted its holdings in Edap Tms by 23.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock valued at $59,000 after acquiring an additional 4,400 shares during the period. Orion Capital Management LLC boosted its position in Edap Tms by 10.4% in the 3rd quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock valued at $178,000 after buying an additional 6,600 shares during the period. Finally, Commonwealth Equity Services LLC raised its holdings in shares of Edap Tms by 5.9% in the second quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock valued at $388,000 after acquiring an additional 4,000 shares in the last quarter. 62.74% of the stock is owned by hedge funds and other institutional investors.
About Edap Tms
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.
Read More
- Five stocks we like better than Edap Tms
- Where to Find Earnings Call Transcripts
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Bank Stocks – Best Bank Stocks to Invest In
- Williams-Sonoma Stock: Buy It and Never Let It Go
- Breakout Stocks: What They Are and How to Identify Them
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.